Health News

New Psoriasis Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new plaque psoriasis drug.
Enbrel Biosimilar Gets Green Light
Enbrel's new biosimilar recently got the green light it needed to treat several inflammatory health conditions.
New Treatment Option for Plaque Psoriasis
The US Food and Drug Administration (FDA) recently approved a new treatment option for adults with moderate to severe plaque psoriasis.
Several New Medications Approved
As a new year begins, we celebrate the beginning of something new and exciting. This year, that includes several new medication approvals from the US Food and Drug Administration (FDA).
Inflammatory Disease Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new medication to treat multiple chronic inflammatory diseases.
Another Biosimilar Gets a Green Light
The US Food and Drug Administration (FDA) has approved another biosimilar. This one is meant to treat multiple conditions that affect the immune system.
New Psoriasis Rx Gets Green Light
The US Food and Drug Administration has approved a new medication to treat psoriasis, a skin condition marked by red patches and flaking, silvery scales.
Approved: First Rx for Plaque Psoriasis in Children
The first-ever medication to treat plaque psoriasis in children has been approved.
Green Light for Biosimilar to Humira
The US Food and Drug Administration has approved its fourth biosimilar.
FDA Approves First Biosimilar Etanercept
The US Food and Drug Administration (FDA) has approved the first biosimilar etanercept.